The outcomes from an Organization for Economic Co-operation and Development (OECD) Working Party on Manufactured Nanomaterials (WPMN) project, “Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk Assessment and Categorization” (NanoAOP) have been officially published in a series of final reports.
Read MoreVireo Advisors is collaborating with Health Canada and two European Horizon2020 projects to coordinate two back-to-back workshops at the OECD: “Advancing Adverse Outcome Pathway (NanoAOP) Development for Nanomaterial Risk Assessment and Categorization” (NanoAOP Workshop), to be held 11 September 2019, and a stakeholder workshop organized by the EU H2020 Project Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS ), to be held 12 September 2019.
Read More